Jason O'Byrne

Insider Reports History

Entity
Individual
Location
Caribou Biociences, Inc., 2929 7 Th Street, Suite 105, Berkeley, CA
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason O'Byrne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vir Biotechnology, Inc. EVP & Chief Financial Officer Common Stock 75K $758K $10.11 Nov 15, 2024 Direct
Caribou Biosciences, Inc. Chief Financial Officer Option to purchase Common Stock 153K $352K $2.69 Feb 20, 2024 Direct
Vir Biotechnology, Inc. EVP & Chief Financial Officer Stock Option (Right to Buy) 150K $230K $1.53 Nov 15, 2024 Direct
Caribou Biosciences, Inc. Chief Financial Officer Common Stock 59.2K $159K $2.69 Feb 20, 2024 Direct

Insider Reports Filed by Jason O'Byrne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIR Vir Biotechnology, Inc. Nov 15, 2024 2 $0 4 Nov 18, 2024 EVP & Chief Financial Officer
VIR Vir Biotechnology, Inc. Oct 2, 2024 0 $0 3 Oct 3, 2024 EVP & Chief Financial Officer
CRBU Caribou Biosciences, Inc. Feb 20, 2024 2 $0 4 Feb 22, 2024 Chief Financial Officer
CRBU Caribou Biosciences, Inc. Feb 21, 2023 1 $0 4 Feb 23, 2023 Chief Financial Officer
CRBU Caribou Biosciences, Inc. Feb 8, 2022 2 $100K 4 Feb 8, 2022 Chief Financial Officer
CRBU Caribou Biosciences, Inc. Dec 20, 2021 1 $0 4 Dec 21, 2021 Chief Financial Officer
CRBU Caribou Biosciences, Inc. Jul 22, 2021 0 $0 3 Jul 22, 2021 Chief Financial Officer Exhibit 24 - Power of Attorney.